Clinical trials: Secondary Pancreatic Diabetes, active
Pancreatic Cancer
Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes
The purpose of this study is to evaluate the efficacy of anti-diabetic treatment on improving the overall survival for metastatic pancreatic cancer patients complicated by diabetes receiving gemcitabine and nab-paclitaxel…
- Trial name
- PTCA199-16 (NCT07272109)
- Testing
- Nab-paclitaxel, Gemcitabine (1000 mg/m2), Anti-Diabetics
- Where
- China
- Volunteers
- 210 people
- Sponsor
- Fudan University
Pancreatic Cancer, Chronic Pancreatitis
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible for the coordination and data management for the Evaluation of a mixed meal test for Diagnosis and characterization of Type 3c diabetes…
- Conditions
- Pancreatic Cancer, Chronic Pancreatitis, Diabetes Mellitus Type 3c
- Trial name
- NCT03460769
- Testing
- Data Management and Monitoring
- Where
- 10 sites in United States
- Volunteers
- 775 people
- Sponsor
- M.D. Anderson Cancer Center